摘要 |
<p>RAN 4019/91 Novel compounds of the formula I wherein B represents a methylene, ethylene or vinylene group, R1 represents a hydrogen atom or an alkyl, aralkyl, amino-alkyl, mono -alkylamino-alkyl, dialkylamino -alkyl, acylamino-alkyl, phthalimido-alkyl, alkoxycarbonylamino -alkyl, aryloxycarbonylamino-alkyl, aralkoxycarbonylamino-alkyl, alkylaminocarbonylamino-alkyl, arylaminocarbonylamino-alkyl, aralkylaminocarbonylamino-alkyl, alkylsulphonylamine-alkyl or arylsulphonylamino -alkyl group, R2 represents a carboxyl, alkoxycarbonyl or aralkoxycarbonyl group or a group of the formula (i) or (ii) , R3 represents a carboxyl, alkoxycarbonyl or aralkoxycarbonyl group, R4 and R5 each represent a hydrogen atom or R4 and R5 together represent an oxo group, R6 and R each represent a hydrogen atom or an alkyl or aralkyl group or R6 and R7 together with the nitrogen atom to which they are attached represent a 5-membered or 6-membered heteromonocyclic ring which may contain a further nitrogen atom or an oxygen or sulphur atom, and n stands for zero, 1 or 2, and pharmaceutically acceptable salts thereof have antihypertensive activity and can be used as medicaments in the form of pharmaceutical preparations.</p> |
申请人 |
HOFFMANN-LA ROCHE LIMITED |
发明人 |
ATTWOOD, MICHAEL R.;HASSALL, CEDRIC H.;LAMBERT, ROBERT W.;LAWTON, GEOFFREY;REDSHAW, SALLY |